Stock ADMIN ADMINISTER OYJ
Add to a list
To use this feature you must be a member
Log inSign up

News Administer Oyj

Equities

ADMIN

FI4000513411

Market Closed - Nasdaq Helsinki
Other stock markets
 06:36:47 2024-05-03 am EDT 		5-day change 1st Jan Change
2.5 EUR 0.00% Intraday chart for Administer Oyj 0.00% +3.73%
Apr. 22 BioXcel Therapeutics to Launch At-Home Trial of Potential Bipolar, Schizophrenia Agitation Treatment MT
Apr. 11 Gerresheimer shares down on outlook, but key contracts confirmed RE

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BioXcel Therapeutics to Launch At-Home Trial of Potential Bipolar, Schizophrenia Agitation Treatment
MT
Gerresheimer shares down on outlook, but key contracts confirmed
RE
Resolutions of Administer Plc’s Annual General Meeting 2024 and the organising meeting of the Board of Directors
AQ
Administer Plc Announces Audit Committee Appointments
CI
Administer Plc Announces No Dividend for the Financial Year Ended 31 December 2023
CI
Administer Plc: Managers' Transactions, Herranen
AQ
Scotland's parliament considers assisted dying as poll shows support
RE
Stoke Therapeutics Rises After Investigational Drug Shows Improvement in Dravet Syndrome Patients
MT
Reinsurance Group in C$5.8 Billion Coinsurance Deal With Canada's Manulife
DJ
Administer Plc’s annual report for the year 2023 has been published
AQ
Administer Plc: Managers' Transactions, Herranen
AQ
Notice to Annual General Meeting of Administer Plc
AQ
Administer Oyj Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Anima sees net outflows, while Fineco, Mediolanum post inflows
RE
Insider information: Administer Group renews its strategy to ensure profitable growth – new financial targets and dividend policy
AQ
Administer Oyj Provides Earnings Guidance for 2026
CI
Administer Plc: Growth continued strong, main focus in increasing profitability
AQ
UK chancellor hopes to reduce tax burden in "prudent" budget
AN
Eagle Plains And Refined Metals Execute Option Agreement For The Dufferin Uranium Project
MT
Arch Biopartners on Pre-IND Meeting With FDA to Repurpose Cilastatin as New Treatment to Prevent Acute Kidney Injury
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ADMIN Stock
  4. News Administer Oyj